Search Results - Jamie E. Chaft

Refine Results
  1. 1
    Immunotherapy in surgically resectable non-small cell lung cancer

    Immunotherapy in surgically resectable non-small cell lung cancer by Dwight H. Owen, Jamie E. Chaft

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Early-stage ALK-positive lung cancer: a narrative review

    Early-stage ALK-positive lung cancer: a narrative review by Monica F. Chen, Jamie E. Chaft

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma

    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma by Jamie E. Chaft, Natasha Rekhtman, Marc Ladanyi, Gregory J. Riely

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist

    Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist by Alexandra Lewis, Jamie E. Chaft, Monica Girotra, Gregory W. Fischer

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

    Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer by Jamie E. Chaft, Yu Shyr, Boris Sepesi, Patrick M. Forde

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Chemotherapy remains an essential element of personalized care for persons with lung cancers

    Chemotherapy remains an essential element of personalized care for persons with lung cancers by Matthew D. Hellmann, Bingyu Li, Jamie E. Chaft, Mark G. Kris

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers

    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers by Juliana Eng, Meier Hsu, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Bob T. Li

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors

    Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors by Jamie E. Chaft, Matthew D. Hellmann, Moises J. Velez, William D. Travis, Valerie W. Rusch

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer by Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris, Tina Cascone

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Cl... by Jamie E. Chaft, Geoffrey R. Oxnard, Camelia S. Sima, Mark G. Kris, Vincent A. Miller, Gregory J. Riely

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung

    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung by Jamie E. Chaft, Camelia S. Sima, Michelle S. Ginsberg, James Huang, Mark G. Kris, William D. Travis, Christopher G. Azzoli

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas

    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas by Melissa L. Johnson, Camelia S. Sima, Jamie E. Chaft, Paul K. Paik, William Pao, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics by Maria E. Arcila, Khédoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas

    Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas by Juliana Schilsky, Ai Ni, Linda S. Ahn, Sutirtha Datta, William D. Travis, Mark G. Kris, Jamie E. Chaft, Natasha Rekhtman, Matthew D. Hellmann

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA

    Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA by Masahiro Tsuboi, Walter Weder, Carles Escriu, Collin M. Blakely, Jianxing He, Sanja Đačić, Yasushi Yatabe, Lingmin Zeng, Andrew Walding, Jamie E. Chaft

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers by Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Prevalence, Clinicopathologic Associations, and Molecular Spectrum of <i>ERBB2</i> (<i>HER2</i>) Tyrosine Kinase Mutations in Lung Adenocarcinomas

    Prevalence, Clinicopathologic Associations, and Molecular Spectrum of <i>ERBB2</i> (<i>HER2</i>) Tyrosine Kinase Mutations in Lung Adenocarcinomas by Maria E. Arcila, Jamie E. Chaft, Khédoudja Nafa, Sinchita Roy‐Chowdhuri, Christopher Lau, Michael Zaidinski, Paul K. Paik, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas

    Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas by Juliana Eng, Kaitlin M. Woo, Camelia S. Sima, Andrew J. Plodkowski, Matthew D. Hellmann, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Marc Ladanyi, Alexander Drilon

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis

    Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis by Nathalie Waser, Melanie Quintana, Bernd Schweikert, Jamie E. Chaft, Lindsay R. Berry, Ahmed Adam, Lien Vo, John R. Penrod, Joseph Fiore, Donald A. Berry, Sarah Goring

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis

    Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis by Manuel Valiente, Anna C. Obenauf, Xin Jin, Qing Chen, Xiang H.-F. Zhang, Derek J. Lee, Jamie E. Chaft, Mark G. Kris, Jason T. Huse, Edi Brogi, Joan Massagué

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: